Title: Yuehu Li - Innovator in Cytotoxicity Targeting Chimeras
Introduction
Yuehu Li is an inventor based in Collegeville, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic agents. Although he currently holds no granted patents, his work is focused on advancing medical treatments through novel molecular designs.
Latest Patent Applications
Yuehu Li has filed several patent applications, including:
1. **Cytotoxicity Targeting Chimeras** - This application relates to heterobifunctional molecules, known as cytotoxicity targeting chimeras (CyTaCs) or antibody recruiting molecules (ARMs). These molecules can simultaneously bind to a target cell-surface protein and an exogenous antibody protein. The application also discusses agents that can bind to receptors on pathogenic cells, inducing their depletion for the treatment of cancer, inflammatory diseases, autoimmune diseases, viral infections, or bacterial infections.
2. **Cytotoxicity Targeting Chimeras for CCR2-Expressing Cells** - Similar to the previous application, this one focuses on heterobifunctional molecules that target CCR2-expressing cells. The goal is to develop agents that can effectively deplete pathogenic cells in various medical conditions.
Conclusion
Yuehu Li is an innovative inventor whose work in cytotoxicity targeting chimeras holds promise for future medical advancements. His contributions to biotechnology may lead to significant breakthroughs in the treatment of various diseases.